Skip to main content
SpringerLink
Log in

Adjuvant Radiotherapy Following Radical Prostatectomy in the Management of Carcinoma of the Prostate

  • Chapter
Carcinoma of the Prostate

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 84 Accesses

Abstract

In the past 5 years in the United States, there has been an unprecedented growth in the incidence of adenocarcinoma of the prostate (CaP). The number of new patients diagnosed with this disease since 1989 has more than doubled. This resulted in CaP becoming the most common human cancer in the United States, representing 36% of all male cancers. In 1995, the American Cancer Society has estimated that 244 000 new patients will be diagnosed with CaP (American Cancer Society 1995). It is expected that 40400 patients will die of CaP in the same year, making CaP the second most important cause of cancer death among American males. The rapid increase in the incidence of CaP can be explained to a large extent by the routine use of the prostate specific antigen (PSA) and by the aging of the American male population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abi-Ada A, MacFarlane MT, Stein A, De Kernion JB (1992) Detection of local recurrence after radical prostatectomy by prostate specific antigen and transurethral ultrasound. J Urol 147: 952–955

    Google Scholar 

  • Adolfsson J (1993) Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol 149: 326–329

    PubMed  CAS  Google Scholar 

  • American Cancer Society (1995) Cancer statistics 1995. CA Cancer J Clin 45: 8–31

    Article  Google Scholar 

  • Anscher MS, Prosnitz LR (1987) Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138: 1407–1412

    PubMed  CAS  Google Scholar 

  • Babaian RJ, Dinney CPN, Ramirez EI, Evans RB (1993) Diagnostic testing for prostate cancer detection: less is best. Urology 41: 421–425

    Article  PubMed  CAS  Google Scholar 

  • Bagshaw MA, Cox RS, Ray GR (1988) Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 7: 47–60

    PubMed  Google Scholar 

  • Bagshaw MA, Cox RS, Ramback JE (1990) Radiation therapy for localized prostate cancer. Justification for long-term follow-up. Urol Clin North Am 17: 787–802

    PubMed  CAS  Google Scholar 

  • Bahnson RR, Garnett JE, Grayhack JT (1986) Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma: preliminary results. Urology 27: 403–406

    Article  PubMed  CAS  Google Scholar 

  • Bosch RJLH, Kurth KH, Schroeder FH (1987) Surgical treatment of locally advanced (T3) prostatic carcinoma: early results. J Urol 138: 816–822

    PubMed  CAS  Google Scholar 

  • Bostwick DG, Graham SD, Napalkow Pet al. (1993) Staging for early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41: 403–411

    Article  PubMed  CAS  Google Scholar 

  • Carter GE, Lieskovsky G, Skinner DG, Petrovich Z (1989) Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy. J Urol 142: 1266–1270

    PubMed  CAS  Google Scholar 

  • Chodak GH, Thisted RA, Gerber G et al. (1994) Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242–248

    Article  PubMed  CAS  Google Scholar 

  • Consensus Conference (1987) The management of clinically localized prostate cancer. JAMA 258: 2727–2730

    Article  Google Scholar 

  • Epstein JI, Carmichael M, Walsh PC (1993a) Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol 149: 1040–1045

    CAS  Google Scholar 

  • Epstein JI, Carmichael M, Partin AW, Walsh PC (1993b) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years follow-up. J Urol 149: 1478–1481

    CAS  Google Scholar 

  • Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1C) prostate cancer. JAMA 271: 368–374

    Article  PubMed  CAS  Google Scholar 

  • Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE (1993) A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269: 2650–2658

    Article  PubMed  CAS  Google Scholar 

  • Formenti S, Lieskovsky G, Simoneau A, Skinner DG, Groshen S, Petrovich Z (1996) Impact of moderate dose postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy. J Urol (in press)

    Google Scholar 

  • Freeman JA, Lieskovsky G, Cook DW, Petrovich X, Chen SC, Groshen S, Skinner DG (1993) Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCNO) prostate cancer from 1976 to 1989: intermediate findings. J Urol 149: 1029–1034

    PubMed  CAS  Google Scholar 

  • Freeman JA, Lieskovsky G, Grossfeld G et al. (1994) Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate. Urology 44: 719–725

    Article  PubMed  CAS  Google Scholar 

  • Gann PH, Hennekens GH, Stampfer MJ (1995) A prospective evaluation of plasma prostate specific antigen for detection of prostatic carcinoma. JAMA 273: 289–294

    Article  PubMed  CAS  Google Scholar 

  • Garnick MB (1994) The dilemmas of prostate cancer. Do the risks of aggressive treatment for early prostate cancer outweigh the benefits? This question is one of the several unresolved issues faced by those who treat, and those who have, prostate cancer. Sci Am 270: 72–81

    Article  PubMed  CAS  Google Scholar 

  • Gibbons RP, Cole BS, Richardson RG et al. (1986) Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135: 65–68

    PubMed  CAS  Google Scholar 

  • Gittes RF (1991) Carcinoma of the prostate. N Engl J Med 324: 236–245

    Article  PubMed  CAS  Google Scholar 

  • Hanks GE, Dawson AK (1986) The role of external beam radiation therapy after prostatectomy for prostate cancer. Cancer 58: 2406–2410

    Article  PubMed  CAS  Google Scholar 

  • Hudson MLA, Catalona WJ (1990) Effects of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 143: 1174–1177

    PubMed  CAS  Google Scholar 

  • Jacobson GM, Smith JA, Stewart JR (1987) Postoperative radiation therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 13: 1021–1024

    Article  PubMed  CAS  Google Scholar 

  • Johansson JE (1994) Watchful waiting for early stage prostate cancer. Urology 43: 138–142

    Article  PubMed  CAS  Google Scholar 

  • Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA (1989) Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 142: 326–331

    PubMed  CAS  Google Scholar 

  • Kaplan ID, Bagshaw MA (1992) Serum prostate-specific antigen after post-prostatectomy radiotherapy. Urology 39: 401–406

    Article  PubMed  CAS  Google Scholar 

  • Kaplan ID, Cox RS, Bagshaw MA (1993) Prostate specific antigen after external beam radiotherapy for prostate cancer: follow-up. J Urol 149: 519–522

    PubMed  CAS  Google Scholar 

  • Koch MO, Smith JA, Hodge EM, Brandell RA (1994) Prospective development of a cost-efficient program for radical retropubic prostatectomy. Urology 44: 311–318

    Article  PubMed  CAS  Google Scholar 

  • Lange PH, Narayan P (1983) Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 21: 113–118

    Article  PubMed  CAS  Google Scholar 

  • Link P, Freiha FS, Stamey TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532–534

    PubMed  CAS  Google Scholar 

  • Mettlin C, Murphy GP, Menck H (1994) Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985–1990. Urology 43: 488–492

    Article  PubMed  CAS  Google Scholar 

  • Morton RA, Steiner MS, Walsh PC (1991) Cancer control following anatomic radical prostatectomy: an interim report. J Urol 145: 1197–1200

    PubMed  CAS  Google Scholar 

  • Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907–923

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Chan DW, Epstein JI et al. (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766–772

    PubMed  CAS  Google Scholar 

  • Partin AW, Yoo J, Carter HB et al. (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150: 110–114

    PubMed  CAS  Google Scholar 

  • Perez CA, Pilepich MV, Garcia D, Simpson JR, Zivnuska F, Hederman MA (1988) Definitive radiation therapy in carcinoma of the prostate localizes to the pelvis: experience at the Mallinckrodt Institute of Radiology. NCI Monogr 7: 85–94

    PubMed  Google Scholar 

  • Perez CA, Cosmatos D, Garcia DM, Eisbruch A, Poulter CA (1993a) Irradiation in relapsing carcinoma of the prostate. Cancer 71: 1110–1122

    Article  CAS  Google Scholar 

  • Perez CA, Hanks GH, Leibel SA, Zietman AL, Fuks Z, Lee RW (1993b) Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. Cancer 72: 3156–3173

    Article  CAS  Google Scholar 

  • Petrovich Z, Lieskovsky G, Langholz B, Luxton G, Jozsef G, Skinner DG (1991) Radiotherapy following radical prostatectomy in patients with carcinoma of the prostate. Int J Radiat Oncol Biol Phys 21: 949–954

    Article  PubMed  CAS  Google Scholar 

  • Pilepich MV, Waltz BJ, Baglan RJ (1984) Postoperative irradiation in carcinoma of the prostate. Int J Radiat Oncol Biol Phys 10: 1869–1873

    Article  PubMed  CAS  Google Scholar 

  • Ray GR, Bagshaw MA, Freiha F (1984) External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926–930

    PubMed  CAS  Google Scholar 

  • Rifkin MD, Zerhouni EA, Gatsonis CA et al. (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 323: 621–626

    Article  PubMed  CAS  Google Scholar 

  • Scardino PT, Frankel JM, Wheeler TM et al. (1986) The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol 135: 510–515

    PubMed  CAS  Google Scholar 

  • Schellhammer PF (1988) Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 31: 191–197

    Article  PubMed  CAS  Google Scholar 

  • Schellhammer PF, El-Mandi AM, Kuban DA (1990) Local failure and related complications after definitive treatment of clinical stage C carcinoma of the prostate by irradiation and surgery. Semin Urol 8: 232–246

    PubMed  CAS  Google Scholar 

  • Schellhammer PF, Schlossberg SM, E1-Mandi AM, Wright GL, Brassil DN (1991) Prostate specific antigen levels after definitive irradiation for carcinoma of the prostate. J Urol 145: 1008–1991

    PubMed  CAS  Google Scholar 

  • Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigini RG (1994) Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc 69: 613–619

    PubMed  CAS  Google Scholar 

  • Shevlin BE, Mittal BB, Brand WN, Shetty RM (1989) The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiat Oncol Biol Phys 16: 1425–1430

    Article  PubMed  CAS  Google Scholar 

  • Stamey TA, Ferrari MK, Schmid HP (1993) The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing value characterize 80% of patients. J Urol 150: 1856–1859

    PubMed  CAS  Google Scholar 

  • Stein A, De Kernion JB, Dorey F, Smith RB (1992) Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. Urology 39: 59–62

    Article  PubMed  CAS  Google Scholar 

  • Steiner MS, Morton RA, Walsh PC (1991) Impact of anatomical radical prostatectomy on urinary continence. J Urol 145: 512–515

    PubMed  CAS  Google Scholar 

  • Van Poppel H, Ameye F, Oyen R, Van der Voorde W, Baert L (1994) Accuracy of combined computerized tomography and fine needle aspiration cytology in lymph node staging of localized prostatic carcinoma. J Urol 151: 1310–1314

    PubMed  Google Scholar 

  • Yamada AH, Lieskovsky G, Petrovich Z, Chen SC, Groshen S, Skinner DG (1994) Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol (CCT) 17: 277–285

    Article  CAS  Google Scholar 

  • Zagars GK, Von Eschenbach AC, Johnson DE, Oswald MJ (1987) Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation. Cancer 60: 1489–1499

    Article  PubMed  CAS  Google Scholar 

  • Zincker H, Utz DC, Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199–1205

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Z. Petrovich MD (Professor of Radiation Oncology and Urology, Chairman) & G. Luxton PhD (Associate Professor of Radiation Oncology)

  2. University of Southern California School of Medicine, 2025 Zonal Avenue, GH 5900, Los Angeles, CA, 90033, USA

    G. Lieskovsky MD (Professor of Urology and Radiation Oncology)

  3. Department of Urology, St. Pieter’s Hospital, Catholic University of Leuven, Brusselsestraat 69, 3000, Leuven, Belgium

    L. Baert MD, PhD (Professor and Chairman, Clinical Professor)

  4. Department of Urology and Radiation Oncology, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    L. Baert MD, PhD (Professor and Chairman, Clinical Professor)

  5. Department of Urology, University of Southern California School of Medicine, 2025 Zonal Avenue, GH 5900, Los Angeles, CA, 90033, USA

    D. G. Skinner MD (Professor and Chairman)

Authors
  1. Z. Petrovich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lieskovsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Luxton PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Baert MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. G. Skinner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology) (Professor, Department of Radiation Oncology and Urology, Chairman, Department of Radiation Oncology)

  2. Department of Urology, St. Pieter’s Hospital, University of Leuven, Brusselsestraat 69, B-3000, Leuven, Belgium

    Luc Baert MD

  3. Department of Radiation Oncology and Nuclear Medicine, Medical College of Pennsylvania and Hahnemann University, 230 N. Broad Street, Philadelphia, PA, 1902-1192, USA

    Luther W. Brady MD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Petrovich, Z., Lieskovsky, G., Luxton, G., Baert, L., Skinner, D.G. (1996). Adjuvant Radiotherapy Following Radical Prostatectomy in the Management of Carcinoma of the Prostate. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Prostate. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60956-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60956-5_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64627-0

  • Online ISBN: 978-3-642-60956-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation